Company profile
SK3 Group, Inc.
OTC: SKTO · Healthcare · Drug Manufacturers - Specialty & Generic
#426 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 38
v0.1 · 5/100 weight · pillars only
↑ operating margin, 3-yr revenue growth · ↓ Altman-Z, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
$17.0M
Employees
15
as of 2026-08-30
Market cap
$3.0k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$52.8M$52.8M2013
Net income$17.0M$17.0M2013
Operating income$26.5M$26.5M2013
Total assets$28.4M$28.4M2013
Liabilities$2.8M$2.8M2013
Equity$25.6M$25.6M2013
Revenue trend
FY2004 – FY2013 · USD
FY04
FY05
FY06
FY07
FY13
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is SK3 Group, Inc.’s revenue?
SK3 Group, Inc. booked $52.8M in FY2013 revenue — among the slowest-growing Healthcare companies we track, at a 32.1% net margin.
Neighbors
Los Angeles →Key facts
CEOArtemus Mayor
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLos Angeles, CA
ExchangeOTC: SKTO
Employees15
IPO date2008-05-15
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.